What is STKL's health score?

SunOpta Inc. (STKL) has a TradeApes health score of 38 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is STKL's estimated fair value?

Based on our 5-year discounted cash flow model, SunOpta Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is STKL undervalued or overvalued?

Our model currently rates STKL as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for STKL... Refresh in a moment for the full analysis.

SunOpta Inc. (STKL)

Consumer Defensive Inconclusive inconclusive weak

$6.5

Updated: 2026-05-30

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

20 Stressed

Relative Value

65 Healthy

Capital Allocation

35 Weak

Risk

50 Mixed

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.